Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
University of Pittsburgh
University of Pittsburgh
Intensity Therapeutics, Inc.
ETOP IBCSG Partners Foundation
NYU Langone Health
Merck Sharp & Dohme LLC
Gritstone bio, Inc.
Gritstone bio, Inc.
Viralytics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital Southampton NHS Foundation Trust